Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $14.7100 (5.94%) ($14.7100 - $14.7100) on Fri. Aug. 27, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.04% (three month average) | RSI | 74 | Latest Price | $14.7100(5.94%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 3.2% a day on average for past five trading days. | Weekly Trend | ATRA advances 5.8% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(52%) ARKG(46%) IBB(46%) ARKK(45%) IWO(43%) | Factors Impacting ATRA price | ATRA will decline at least -1.52% in a week (0% probabilities). VIXM(-37%) VXX(-28%) IGOV(-15%) UNG(-13%) TLT(-10%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.52% (StdDev 3.04%) | Hourly BBV | 2 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $13.9(5.83%) | 10 Day Moving Average | $13.21(11.36%) | 20 Day Moving Average | $12.92(13.85%) | To recent high | -11.2% | To recent low | 22.5% | Market Cap | $1.093b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |